NewVale Capital led the investment round.
Beaconcure’s platform Verify automates the clinical trial data analysis process. Additionally, the company named Craig Lipstat, the former head of clinical innovation at Pfizer, to its strategic advisory board, according to a June 13 Beaconcure news release.
“Beaconcure has a clear mission: to reduce the cost and time to complete every clinical trial,” Yoran Bar, co-founder and CEO of Beaconcure, said in the news release. “Verify is just the beginning and we are excited to bring our new platform to life and to empower clinicians, statistical programmers, and medical writers with a powerful set of tools that were previously unavailable.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.